Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 57 | +10 |
| Shares | 6.36M | 44.0K | 5.72M | −591.7K (−9.4%) |
| Value | $20.4M | $145.2K | $11.5M | −$8.83M (−43.5%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 206,800 | $426.0K | 0.00% |
| Marshall Wace, LLP | 67,418 | $138.9K | 0.00% |
| Two Sigma Investments, LP | 49,027 | $101.0K | 0.00% |
| LPL Financial LLC | 41,541 | $85.6K | 0.00% |
| Mirador Capital Partners LP | 25,084 | $51.7K | 0.01% |
| Occudo Quantitative Strategies LP | 24,395 | $50.3K | 0.01% |
| Janney Montgomery Scott LLC | 20,000 | $41.0K | 0.00% |
| Professional Financial Advisors, LLC | 17,279 | $35.6K | 0.02% |
| Kingswood Wealth Advisors, LLC | 16,600 | $34.2K | 0.01% |
| Socha Financial Group, LLC | 12,380 | $25.5K | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 11,861 | $24.4K | 0.00% |
| Virtu Financial LLC | 10,884 | $22.0K | 0.00% |
| VisionPoint Advisory Group, LLC | 1,944 | $4.00K | 0.00% |
| Cypress Capital Management LLC (WY) | 1,000 | $2.06K | 0.00% |
| St Germain D J Co Inc | 500 | $1.03K | 0.00% |
Sold out (5)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Simplex Trading, LLC | 183,390 | $605.0K |
| Group One Trading, L.P. | 162,753 | $537.1K |
| XTX Topco Ltd | 12,227 | $40.3K |
| Raymond James Financial Services Advisors, Inc. | 11,248 | $37.1K |
| FMR LLC | 400 | $1.32K |
Not filed for Q2 2023 yet (1)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Tru Independence Asset Management 2, LLC | 44,000 | $145.2K |